RECURRENT PITUITARY APOPLEXY IN AN ADENOMA WITH SWITCHING PHENOTYPES
| Autor: | Kalmon D. Post, Teresa Brown, Khadeen C. Cheesman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Transsphenoidal surgery
Pathology medicine.medical_specialty Adenoma business.industry medicine.medical_treatment Pituitary tumors Pituitary apoplexy 030209 endocrinology & metabolism General Medicine Adrenocorticotropic hormone Case Reports medicine.disease RC648-665 Diseases of the endocrine glands. Clinical endocrinology 03 medical and health sciences 0302 clinical medicine Pituitary adenoma 030220 oncology & carcinogenesis medicine business Luteinizing hormone Hormone |
| Zdroj: | AACE Clin Case Rep AACE Clinical Case Reports, Vol 6, Iss 5, Pp e221-e224 (2020) |
| Popis: | Objective To describe an unusual presentation of a patient with recurrent pituitary apoplexy of an adenoma that switched phenotypes from a nonfunctioning, or silent gonadotroph adenoma (SGA), to a silent corticotroph adenoma (SCA). We discuss the potential etiologies of both recurrent pituitary apoplexy and phenotype switching of pituitary tumors. Methods The presented case includes clinical and biochemical findings, surgical outcomes, and pathologic reports related to the treatment of our patient who presented with recurrent pituitary apoplexy. Results A 56-year-old man presented for evaluation of decreased libido and was found to have a low testosterone level. A pituitary magnetic resonance image demonstrated an 8-mm pituitary adenoma. He underwent transsphenoidal surgery (TSS) to remove the tumor and pathology demonstrated an SGA immunopositive for luteinizing hormone and follicle-stimulating hormone with evidence of apoplexy. Eight years later, the patient underwent another TSS after developing acute-onset headache, vomiting, and a cranial nerve palsy. Pathology at this time showed a necrotic tumor consistent with apoplexy with negative immunostains for all pituitary tumors. Three years after this, the tumor recurred and after another TSS the tumor stained positive for adrenocorticotropic hormone but was negative for luteinizing hormone and follicle-stimulating hormone with hemorrhage consistent with apoplexy. A few years afterward, he again developed acute-onset headache and cranial nerve palsies and had another TSS. On pathology, the tumor demonstrated extensive necrosis consistent with apoplexy and again stained positive for adrenocorticotropic hormone. The patient was then referred for radiation therapy and was subsequently lost to follow up. Conclusion Recurrent pituitary apoplexy in the same patient has only been described 3 times in the literature. There have been no case reports of a pituitary adenoma that switched phenotypes from an SGA to SCA. We suggest that pituitary apoplexy may recur multiple times due to a tumor with particularly fragile vessel walls and increased vascularization. We review the literature that suggests clinical and molecular similarities between SGAs and SCAs. Further studies are needed to determine the etiologies of recurrent apoplexy and pituitary adenomas with switching phenotypes. Abbreviations ACTH adrenocorticotropic hormone FSH follicle-stimulating hormone GH growth hormone LH luteinizing hormone MRI magnetic resonance imaging SCA silent corticotroph adenoma SGA silent gonadotroph adenoma TSH thyroid-stimulating hormone TSS transsphenoidal surgery VEGF vascular endothelial growth factor |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|